RESEARCH PAPER
HIV visibility among people living with HIV in the central of Iran
 
More details
Hide details
1
Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran
 
2
Department of Epidemiology and Biostatistics, School of Health, Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
 
3
Deputy of Health, Arak University of Medical Sciences, Arak, Iran
 
 
Submission date: 2023-10-21
 
 
Final revision date: 2024-01-20
 
 
Acceptance date: 2024-01-26
 
 
Publication date: 2025-03-31
 
 
Corresponding author
Rahmatollah Moradzadeh   

Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran.
 
 
HIV & AIDS Review 2025;24(1):68-74
 
KEYWORDS
TOPICS
ABSTRACT
Background:
Human Immunodeficiency Virus (HIV) has had far-reaching consequences for humans as a socio-medical problem. This study aimed to estimate HIV visibility by different categories of social network and their relevant factors.

Material and methods:
This cross-sectional study was conducted in Markazi province of Iran. A total of 123 People living with HIV (PLWH) were recruited. A comprehensive list of relationships was provided and the extent to which the participants’ acquaintances were aware of their disease was asked. The 95% confidence interval (CI) of visibility rates was obtained through bootstrapping procedure. The potential determinants of HIV visibility were modelled with zero-inflated negative binomial regression analysis.

Results:
The visibility of HIV was estimated to be 14.8% (11.3% to 18.3%). HIV was much more visible to one’s spouse than to others (83%); HIV visibility was more for family members than non-family members, for the consanguineal family than affinal family, and for immediate family than extended family members. The duration of HIV disease, the socioeconomic status level, the transmission route and the closeness of acquaintances were the important determinants of HIV visibility.

Conclusions:
The visibility of HIV in this study was very low. A disclosure decision is a potentially critical decision and could have negative and positive consequences. The whole society, including PLWH and other people, could benefit from interventions helping raise HIV disclosure. Moreover, there is need to adjust the estimated parameters based on the estimated HIV visibility.
REFERENCES (33)
1.
UNAIDS. Global HIV & AIDS statistics – 2020 fact sheet. Avail- able from: https://wwwunaidsorg/en/resour... (Accessed: 21.02.2021).
 
2.
Sassanid L, Naji A, Abedi HA, Taeri K. The experience of social stigma in AIDS patients: a phenomenological study. Journal of Sabzevar University of Medical Sciences 2014; 20: 487-495 [In Persian].
 
3.
Infectious Disease Management Center (CDC). The latest statistics related to HIV infection in the Islamic Republic of Iran (by the End of the september 2020). Tehran, Iran: Ministry of Health and Medical Education(MOHME); 2020. Contract No.: 1 [In Persian] Ignatius E, Kokkonen M. Factors contributing to verbal self-disclosure. Nordic Psychol 2007; 59: 362-391.
 
4.
Ebrahimi F, Sindarreh S, Nasirian M. Human immunodeficiency virus (HIV) stigma among general population in Isfahan metropolis in Central Iran. Journal of HIV/AIDS & Social Services 2020; 19: 220-230.
 
5.
Jorjoran Shushtari Z, Sajjadi H, Forouzan AS, Salimi Y, Dejman M. Disclosure of HIV status and social support among people living with HIV. Iran Red Crescent Med J 2014; 16: e11856. DOI: 10.5812/ircmj.11856
 
6.
Behboodi-Moghadam Z, Khalajinia Z, Nasrabadi ARN, Mohraz M, Gharacheh M. Pregnancy through the lens of Iranian women with HIV: a qualitative study. J Int Assoc Provid AIDS Care 2016; 15: 148-152.
 
7.
Zamanian M, Zolala F, Haghdoost AA, Baneshi MR. Estimating the annual abortion rate in Kerman, Iran: comparison of direct, network scale-up, and single sample count methods. Int J Fertil Steril 2019; 13: 209-214.
 
8.
Rastegari A, Haji-Maghsoudi S, Haghdoost A, Shatti M, Tarjoman T, Baneshi MR. The estimation of active social network size of the Iranian population. Glob J Health Sci 2013; 5: 217-227.
 
9.
Avanessian E, Naserirad M, Abrahamian H, Anis S. Size of social network and probability of occurrence of HIV/AIDS among sexually affected patients in behavioral diseases consulting centers. Iran J Health Educ Health Promot 2017; 5: 73-80.
 
10.
Levy A, Laska F, Abelhauser A, Delfraissy JF, Goujard C, Boue F, et al. Disclosure of HIV seropositivity. J Clin Psychol 1999; 55: 1041-1049.
 
11.
Simbayi LC, Kalichman SC, Strebel A, Cloete A, Henda N, Mqeketo A. Disclosure of HIV status to sex partners and sexual risk behaviours among HIV-positive men and women, Cape Town, South Africa. Sex Transm Infect 2007; 83: 29-34.
 
12.
Chandra PS, Deepthivarma S, Manjula V. Disclosure of HIV infection in South India: patterns, reasons and reactions. AIDS Care 2003; 15: 207-215.
 
13.
Yang X, James TA, Brown MJ, Brown T, Zarsadias S, Zhang R, et al. Patterns of HIV disclosure and its impact on the HIV care continuum among black men who have sex with men in South Carolina. Am J Mens Health 2023; 17: 15579883231177981. DOI: 10.1177/15579883231177981.
 
14.
Logie CH, Lacombe-Duncan A, Brien N, Jones N, Lee-Foon N, Levermore K, et al. Barriers and facilitators to HIV testing among young men who have sex with men and transgender women in Kingston, Jamaica: a qualitative study. J Int AIDS Soc 2017; 20: 21385. DOI: 10.7448/IAS.20.1.21385.
 
15.
Iran Statistical Yearbook 1396. 2017. Available from: https://www.amar.org.ir/Portal... (Accessed: 21.02.2021).
 
16.
Zamanian M, Zolala F, Haghdoost AA, Haji-Maghsoudi S, Heydari Z,.
 
17.
Baneshi MR. Methodological considerations in using the Network Scale Up (NSU) for the estimation of risky behaviors of particular age-gender groups: an example in the case of intentional abortion. PLoS One 2019; 14: e0217481. DOI: 10.1371/journal.pone.
 
18.
Zamanian M, Zolala F, Haghdoost AA, Baneshi MR. Effect of estimation method, definition of ratio, and the plausible range in esti­mating social network size. Social Network Analysis and Mining 2018; 8: 1-7.
 
19.
Reinius M, Wettergren L, Wiklander M, Svedhem V, Ekström AM, Eriksson LE. Development of a 12-item short version of the HIV stigma scale. Health Qual Life Outcomes 2017; 15: 115. DOI: 10.1186/s12955-017-0691-z.
 
20.
Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan 2006; 21: 459-468.
 
21.
Saki M, Kermanshahi SMK, Mohammadi E, Mohraz M. Perception of patients with HIV/AIDS from stigma and discrimination. Iran Red Crescent Med J 2015; 17: e23638. DOI: 10.5812/ircmj.23638v2.
 
22.
Stutterheim SE, Brands R, Baas I, Lechner L, Kok G, Bos AE. HIV status disclosure in the workplace: positive and stigmatizing experiences of health care workers living with HIV. J Assoc Nurs AIDS Care 2017; 28: 923-937.
 
23.
Stutterheim SE, Bos AE, Van Kesteren NM, Shiripinda I, Pryor JB, De Bruin M, et al. Beliefs contributing to HIV‐related stigma in African and Afro‐Caribbean communities in the Netherlands. J Commun Appl Soc Psychol 2012; 22: 470-484.
 
24.
Moradzadeh R, Zamanian M. HIV-related stigma among people living with HIV in Iran: a cross-sectional study. J Assoc Nurses AIDS Care 2021; 32: 610-618.
 
25.
George MS, Lambert H. ‘I am doing fine only because I have not told anyone’: the necessity of concealment in the lives of people living with HIV in India. Cult Health Sex 2015; 17: 933-946.
 
26.
Bouillon K, Lert F, Sitta R, Schmaus A, Spire B, Dray-Spira R. Factors correlated with disclosure of HIV infection in the French Antilles and French Guiana: results from the ANRS-EN13-VESPA- DFA Study. AIDS 2007; 21 Suppl 1: S89-S94.
 
27.
Peltzer K, Mlambo G. HIV disclosure among HIV positive new mothers in South Africa. Journal of Psychology in Africa 2013; 23: 327-333.
 
28.
Hardon A, Vernooij E, Bongololo-Mbera G, Cherutich P, Desclaux A, Kyaddondo D, et al. Women’s views on consent, counseling and confidentiality in PMTCT: a mixed-methods study in four African countries. BMC Public Health 2012; 12: 26. DOI: 10.1186/1471-2458- 12-26.
 
29.
Zamanian M, Baneshi MR, Haghdoost A, Zolala F. Estimating the visibility rate of abortion: a case study of Kerman, Iran. BMJ Open 2016; 6: e012761. DOI: 10.1136/bmjopen-2016-012761.
 
30.
Loutfy MR, Logie CH, Zhang Y, Blitz SL, Margolese SL, Tharao WE, et al. Gender and ethnicity differences in HIV-related stigma experienced by people living with HIV in Ontario, Canada. PLoS One 2012; 7: e48168. DOI: 10.1371/journal.pone.0048168.
 
31.
Balvardi M, Dehdashti N, Imani Ghoghary Z, Bashiri H, Alavi Arjas F. Prevalence of sexual behaviors among medical students in Southeast of Iran. Iran J Health Sci 2022; 10: 32-43.
 
32.
Antelman G, Fawzi MCS, Kaaya S, Mbwambo J, Msamanga GI, Hunter DJ, et al. Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS 2001; 15: 1865-1874.
 
33.
Farquhar C, Ngacha D, Bosire R, Nduati R, Kreiss J, John G (eds.). Prevalence and correlates of partner notification regarding HIV-1 in an antenatal setting in Nairobi, Kenya. XIII International AIDS Conference; 2000.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top